Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT01864746||Active, not recruiting||A Study of Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery||
||Other / Industry||
||1250||Female||18 Years and older (Adult, Older Adult)||NCT01864746||GBG78/BIG 1-13/NSABP-B-54-I
|PENELOPE-B||November 2013||December 2020||November 2023||May 30, 2013||February 28, 2018||